Recro Pharma Inc (REPH) Insider Trading

Total insider buys:
  • $15,432,705.22
Total insider sells:
  • $23,515,395.34
Most recent insider trade:
  • July 15, 2022
Most active insider trader:
  • Healthcare Master Fun Broadfin
Trader NameDateTitleAmountPriceTypeTotal Value
July 15, 2022Chief Executive Officer1,150$0.81Buy$931.50
March 18, 2022Director1,000$2.15Buy$2,150.00
March 15, 2022CEO512$1.96Buy$1,003.52
Feb. 15, 2022CEO571$1.77Buy$1,010.67
Jan. 18, 2022CEO602$1.68Buy$1,011.36
Dec. 21, 2021Major Shareholder99,398$1.55Sell$154,066.90
Dec. 15, 2021CEO617$1.61Buy$993.37
Dec. 15, 2021Major Shareholder20,000$1.63Sell$32,600.00
Dec. 13, 2021Major Shareholder20,000$1.63Sell$32,600.00
Nov. 17, 2021Director1,000$1.69Buy$1,690.00
Nov. 12, 2021CFO1,212$1.65Buy$1,999.80
Nov. 12, 2021CEO1,725$1.68Buy$2,898.00
Dec. 22, 2020Major Shareholder18,830$3.17Sell$59,691.10
Dec. 18, 2020Major Shareholder6,208$3.03Sell$18,810.24
April 17, 2020CEO80,000$8.22Sell$657,600.00
May 17, 2019Director40,000$9.00Buy$360,000.00
May 13, 2019CEO144,806$8.89Sell$1,287,325.34
May 24, 2018Major Shareholder188,000$5.81Sell$1,092,280.00
March 13, 2018Major Shareholder200,000$10.07Sell$2,014,000.00
Jan. 3, 2018Major Shareholder12,964$8.88Sell$115,120.32
Dec. 29, 2017Major Shareholder18,231$9.27Sell$169,001.37
Dec. 28, 2017Major Shareholder1,980$9.44Sell$18,691.20
Dec. 27, 2017Major Shareholder13,189$9.56Sell$126,086.84
Dec. 21, 2017Major Shareholder76,000$9.87Sell$750,120.00
Dec. 13, 2017Major Shareholder93,237$9.86Sell$919,316.82
Dec. 5, 2017Major Shareholder100,000$10.00Sell$1,000,000.00
Nov. 30, 2017Major Shareholder222,616$9.58Sell$2,132,661.28
Nov. 28, 2017Major Shareholder47,549$9.64Sell$458,372.36
Nov. 24, 2017Major Shareholder172,208$9.45Sell$1,627,365.60
Nov. 21, 2017Major Shareholder102,440$9.50Sell$973,180.00
June 14, 2017Insider110,447$6.39Sell$705,756.33
June 13, 2017Major Shareholder32,447$6.59Sell$213,825.73
June 12, 2017Major Shareholder10,000$6.74Sell$67,400.00
June 8, 2017Insider62,868$7.06Sell$443,848.08
May 12, 2017Major Shareholder510,000$7.40Sell$3,774,000.00
May 11, 2017Major Shareholder244,629$7.65Sell$1,871,411.85
May 4, 2017Major Shareholder217,308$7.70Sell$1,673,271.60
March 16, 2017Major Shareholder44,977$8.00Sell$359,816.00
Feb. 17, 2017Major Shareholder9,983$7.59Sell$75,770.97
Feb. 16, 2017Major Shareholder4,030$7.89Sell$31,796.70
Dec. 16, 2016Director800$6.71Buy$5,368.00
Dec. 15, 2016Director1,500$6.55Buy$9,825.00
Dec. 13, 2016Major Shareholder650,000$6.00Buy$3,900,000.00
Aug. 16, 2016Major Shareholder390,000$7.50Buy$2,925,000.00
May 31, 2016Insider1,250$8.22Buy$10,275.00
May 23, 2016Major Shareholder2,503$6.30Sell$15,768.90
May 23, 2016VP2,000$6.30Buy$12,600.00
May 20, 2016Director58,331$7.91Sell$461,398.21
May 20, 2016Major Shareholder6,260$6.46Sell$40,439.60
May 19, 2016CAO1,140$6.48Buy$7,387.20
First«1 of 2»Last
  • Insiders are both buying and selling Recro Pharma Inc stock.

  • The insider traders at Recro Pharma Inc are: Healthcare Master Fun Broadfin, Scp Vitalife Partners (Israel), J David Enloe Jr, Scp Vitalife Partners Ii Lp, James E Flynn, Geraldine Henwood, Awm Investment Company, Inc., Stonepine Capital Management,, James Charles Miller, Charles Garner, Donna Nichols, Winston J Churchill, Arnaud Ajdler, ENLOE J DAVID JR, Karen Flynn, Randall Mack, Ryan David Lake, Stewart Mccallum, and Alfred Altomari

  • The most active insider trader at Recro Pharma Inc is Healthcare Master Fun Broadfin with 13 trades.

  • Healthcare Master Fun Broadfin has sold the most Recro Pharma Inc stock with a total value of $12,059,576.06.

  • Healthcare Master Fun Broadfin has bought the most Recro Pharma Inc stock with a total value of $18,828,359.80.

  • The most recent insider trade for Recro Pharma Inc was on July 15, 2022.

  • The single biggest insider buy for Recro Pharma Inc was from Healthcare Master Fun Broadfin with a total value of $7,500,014.80 on July 7, 2015.

  • The single biggest insider sell for Recro Pharma Inc was from Stonepine Capital Management, with a total value of $3,774,000.00 on May 12, 2017.